Literature DB >> 17965731

Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line.

N Rimmerman1, H V Hughes, H B Bradshaw, M X Pazos, K Mackie, A L Prieto, J M Walker.   

Abstract

BACKGROUND AND
PURPOSE: N-arachidonoyl ethanolamine (AEA) and 2-arachidonoyl glycerol (2-AG) are endogenous cannabinoids binding to the cannabinoid receptors CB1 and CB2 to modulate neuronal excitability and synaptic transmission in primary afferent neurons. To investigate the compartmentalization of the machinery for AEA and 2-AG signalling, we studied their partitioning into lipid raft fractions isolated from a dorsal root ganglion X neuroblastoma cell line (F-11). EXPERIMENTAL APPROACH: F-11 cells were homogenized and fractionated using a detergent-free OptiPrep density gradient. All lipids were partially purified from methanolic extracts of the fractions on solid phase cartridges and quantified using liquid chromatography tandem mass spectrometry (LC/MS/MS). Protein distribution was determined by Western blotting. KEY
RESULTS: Under basal conditions, the endogenous cannabinoid AEA was present in both lipid raft and specific non-lipid raft fractions as was one of its biosynthetic enzymes, NAPE-PLD. The 2-AG precursor 1-stearoyl-2-arachidonoyl-sn-glycerol (DAG), diacylglycerol lipase alpha (DAGLalpha), which cleaves DAG to form 2-AG, and 2-AG were all co-localized with lipid raft markers. CB1 receptors, previously reported to partition into lipid raft fractions, were not detected in F-11 membranes, but CB2 receptors were detected at high levels and partitioned into non-lipid raft fractions. CONCLUSIONS AND IMPLICATIONS: The biochemical machinery for the production of 2-AG via the putative diacylglycerol pathway is localized within lipid rafts, suggesting that 2-AG synthesis via DAG occurs within these microdomains. The observed co-localization of AEA, 2-AG, and their synthetic enzymes with the reported localization of CB1 raises the possibility of intrinsic-autocrine signalling within lipid raft domains and/or retrograde-paracrine signalling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17965731      PMCID: PMC2219527          DOI: 10.1038/sj.bjp.0707561

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  75 in total

1.  Metabotropic suppression of excitation in murine autaptic hippocampal neurons.

Authors:  Alex Straiker; Ken Mackie
Journal:  J Physiol       Date:  2006-11-16       Impact factor: 5.182

Review 2.  Hydrophobic modifications of Ras proteins by isoprenoid groups and fatty acids--More than just membrane anchoring.

Authors:  Markos Pechlivanis; Juergen Kuhlmann
Journal:  Biochim Biophys Acta       Date:  2006-10-04

3.  Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells.

Authors:  Monica Bari; Paola Spagnuolo; Filomena Fezza; Sergio Oddi; Nicoletta Pasquariello; Alessandro Finazzi-Agrò; Mauro Maccarrone
Journal:  J Immunol       Date:  2006-10-15       Impact factor: 5.422

4.  A biosynthetic pathway for anandamide.

Authors:  Jie Liu; Lei Wang; Judith Harvey-White; Douglas Osei-Hyiaman; Raj Razdan; Qian Gong; Andrew C Chan; Zhifeng Zhou; Bill X Huang; Hee-Yong Kim; George Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

Review 5.  Lipid rafts: at a crossroad between cell biology and physics.

Authors:  Ken Jacobson; Ole G Mouritsen; Richard G W Anderson
Journal:  Nat Cell Biol       Date:  2007-01       Impact factor: 28.824

6.  The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism.

Authors:  Daniela Sarnataro; Simona Pisanti; Antonietta Santoro; Patrizia Gazzerro; Anna Maria Malfitano; Chiara Laezza; Maurizio Bifulco
Journal:  Mol Pharmacol       Date:  2006-07-05       Impact factor: 4.436

Review 7.  Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.

Authors:  Takayuki Sugiura; Seishi Kishimoto; Saori Oka; Maiko Gokoh
Journal:  Prog Lipid Res       Date:  2006-04-19       Impact factor: 16.195

8.  Raft association and lipid droplet targeting of flotillins are independent of caveolin.

Authors:  Lawrence Rajendran; Soazig Le Lay; Harald Illges
Journal:  Biol Chem       Date:  2007-03       Impact factor: 3.915

9.  Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators.

Authors:  Heather B Bradshaw; Neta Rimmerman; Jocelyn F Krey; J Michael Walker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-03-23       Impact factor: 3.619

10.  Cannabinoid CB1 receptor recognition of endocannabinoids via the lipid bilayer: molecular dynamics simulations of CB1 transmembrane helix 6 and anandamide in a phospholipid bilayer.

Authors:  Diane L Lynch; Patricia H Reggio
Journal:  J Comput Aided Mol Des       Date:  2006-11-14       Impact factor: 4.179

View more
  32 in total

Review 1.  Molecular model of cannabis sensitivity in developing neuronal circuits.

Authors:  Erik Keimpema; Ken Mackie; Tibor Harkany
Journal:  Trends Pharmacol Sci       Date:  2011-07-13       Impact factor: 14.819

2.  Microdialysis Coupled with LC-MS/MS for In Vivo Neurochemical Monitoring.

Authors:  Alexander G Zestos; Robert T Kennedy
Journal:  AAPS J       Date:  2017-06-28       Impact factor: 4.009

Review 3.  Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls.

Authors:  Matthew W Buczynski; Loren H Parsons
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

4.  Mass Spectrometry Imaging and GC-MS Profiling of the Mammalian Peripheral Sensory-Motor Circuit.

Authors:  Stanislav S Rubakhin; Alexander Ulanov; Jonathan V Sweedler
Journal:  J Am Soc Mass Spectrom       Date:  2015-03-31       Impact factor: 3.109

5.  Mouse Neuroblastoma CB1 Cannabinoid Receptor-Stimulated [35S]GTPɣS Binding: Total and Antibody-Targeted Gα Protein-Specific Scintillation Proximity Assays.

Authors:  Khalil Eldeeb; Sandra Leone-Kabler; Allyn C Howlett
Journal:  Methods Enzymol       Date:  2017-07-19       Impact factor: 1.600

6.  Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin-1.

Authors:  Neta Rimmerman; Heather B Bradshaw; Ewa Kozela; Rivka Levy; Ana Juknat; Zvi Vogel
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

7.  Good news for CB1 receptors: endogenous agonists are in the right place.

Authors:  M Maccarrone
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

Review 8.  Lipid rafts in neurodegeneration and neuroprotection.

Authors:  Sandro Sonnino; Massimo Aureli; Sara Grassi; Laura Mauri; Simona Prioni; Alessandro Prinetti
Journal:  Mol Neurobiol       Date:  2013-12-22       Impact factor: 5.590

Review 9.  Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown.

Authors:  Ekaterina A Placzek; Yasuo Okamoto; Natsuo Ueda; Eric L Barker
Journal:  Neuropharmacology       Date:  2008-08-08       Impact factor: 5.250

10.  Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.

Authors:  Maria Teresa Cencioni; Valerio Chiurchiù; Giuseppina Catanzaro; Giovanna Borsellino; Giorgio Bernardi; Luca Battistini; Mauro Maccarrone
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.